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Pepsin-Mediated Processing of the Cytoplasmic Histone H2A
to Strong Antimicrobial Peptide Buforin I1
Hun Sik Kim,* Ho Yoon,† Il Minn,* Chan Bae Park,* Won Taek Lee,‡ Michael Zasloff,§ and
Sun Chang Kim2*
The intestinal epithelium forms a first line of innate host defense by secretion of proteins with antimicrobial activity against
microbial infection. Despite the extensive studies on the antimicrobial host defense in many gastrointestinal tracts, little is known
about the antimicrobial defense system of the stomach. The potent antimicrobial peptide buforin I, consisting of 39 aa, was isolated
recently from the stomach tissue of an Asian toad, Bufo bufo gargarizans. In this study we examined the mechanism of buforin
I production in toad stomach tissue. Buforin I is produced by the action of pepsin isozymes, named pepsin Ca and Cb, cleaving
the Tyr39-Ala40 bond of histone H2A. Immunohistochemical analysis revealed that buforin I is present extracellularly on the
mucosal surface, and unacetylated histone H2A, a precursor of buforin I, is localized in the cytoplasm of gastric gland cells.
Furthermore, Western blot analysis showed that buforin I is also present in the gastric fluids, and immunoelectron microscopy
detected localization of the unacetylated histone H2A in the cytoplasmic granules of gastric gland cells. The distinct subcellular
distribution of the unacetylated histone H2A and the detection of the unacetylated buforin I both on the mucosal surface and in
the lumen suggest that buforin I is produced from the cytoplasmic unacetylated histone H2A secreted into the gastric lumen and
subsequently processed by pepsins. Our results indicate that buforin I along with pepsins in the vertebrate stomach may contribute
to the innate host defense of the stomach against invading microorganisms. The Journal of Immunology, 2000, 165: 3268–3274.
V ertebrates have natural defense mechanisms that protectagainst invading microorganisms that can easily pene-trate the epithelia of the respiratory, gastrointestinal, and
genitourinary tract (1). Most of the exposure to bacteria occurs in
the gastrointestinal tract. Because most mucosal surfaces do not
normally contain abundant phagocytic cells, surface epithelial cells
are of critical importance in mediating the innate protection of the
host from microbial infection. This requires a pre-existing or rap-
idly responsive antimicrobial defense against microbial invasion.
The role of gastric acid and peristaltic activity has long been rec-
ognized in the maintenance of relative sterility of the gastrointes-
tinal tract (2, 3). However, recent studies have shown that enteric
bacteria are able to survive the acidic conditions encountered in the
stomach (4, 5), suggesting that the present concept of the role of
gastric acid in the bacterial clearance is not sufficient and needs to
be modified. Antimicrobial peptides are important components of
the natural defenses of most living organisms against microbial
infection (6). Antimicrobial peptides play an important role in mu-
cosal defense and are often found in high concentrations on dam-
aged mucosal surfaces, including the tongue, trachea, and intestine
(7). The expression of individual members of gene families that
encode antimicrobial peptides is tissue specific. Antimicrobial pep-
tides can function intracellularly, as in circulating leukocytes or in
the external environment after release by secretory cells and other
granulated epithelia (8). Certain antimicrobial peptides have diverse
functions beyond microbicidal activity, such as promotion of wound
healing (9) and chemotaxis of dendritic and memory T cells (10).
Although peptide antimicrobials have been purified and charac-
terized extensively, their biological functions and the nature of
their post-translational processing are not yet well understood. The
most studied antimicrobial peptides are cecropins (11), bactenecins
(12), and defensins (13, 14). The delineation of biosynthetic and
maturation processes of antimicrobial peptides may help to define
more accurately their in vivo functions. Recently, a potent antimi-
crobial peptide consisting of 39 aa, termed buforin I, was isolated
from the stomach of an Asian toad (15). Sequencing of the cDNA
encoding buforin I revealed its precursor to be histone H2A (16).
However, the protease that is responsible for the generation of
buforin I from histone H2A has not been identified. Furthermore,
the involvement of histone H2A as a precursor of potent antimi-
crobial peptide raises many interesting questions about the cellular
processing mechanism of histone H2A in the innate host defense
of vertebrate stomach. In this study we describe the mechanism for
the generation of buforin I from histone H2A. We also show that
buforin I constitutes an innate host defense system that is operative
at the mucosal layer and lumen of the vertebrate gastrointestinal
tract.
Materials and Methods
Materials
Calf thymus histone H2A, pepstatin A, leupeptin, and E-64 were purchased
from Roche (Mannheim, Germany). PMSF, pepstatin A-Agarose, and por-
cine pepsin A (crystallized and prepared chromatographically) were ob-
tained from Sigma (St. Louis, MO). To remove any contaminating pepsin
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C, pepsin A was subjected to chromatography on a Mono Q HR 5/5 (Phar-
macia LKB, Uppsala, Sweden) column that had been equilibrated with
pyridine-acetate buffer, pH 6.0. All other reagents used in this study were
of analytical grade.
Assay for proteolytic activity
Crude extracts of toad stomachs were prepared as described by Kim et al.
(16). Proteolytic cleavage of histone H2A was examined by incubating calf
thymus histone H2A (10 mg) with crude stomach extracts (5 mg) in reac-
tion buffers ranging in pH from 1.0 to 11.0 (total reaction volume, 50 ml).
After incubation for 1 h at room temperature, the reactions were stopped by
boiling for 5 min and were analyzed by tricine SDS-PAGE. For protease
inhibition assays, crude stomach extracts (5 mg) were preincubated for 1 h
at room temperature with each of the following protease inhibitors: PMSF
(10 mM), leupeptin (50 mM), pepstatin A (50 mM), EDTA (5 mM), and
E-64 (50 mM). Histone H2A (10 mg) was then added, and the protease
reactions were allowed to proceed for an additional hour (final reaction
volume, 50 ml in reaction buffer).
Purification of specific proteases
Crude stomach extracts that contained ;50 mg of proteins (5 mg/ml) were
acidified to pH 3.0 and loaded into a column of pepstatin A-Agarose, which
had been equilibrated at 4°C with 50 mM sodium acetate (pH 3.0) con-
taining 0.2 M NaCl. The column was washed with the same buffer at a flow
rate of 0.2 ml/min until the absorbance at 280 nm fell to the baseline.
Proteins of interest were then eluted at the same flow rate with 50 mM
Tris-HCl (pH 8.5) containing 1 M NaCl. Fractions (1 ml) were collected
and analyzed for proteolytic activity at pH 3.0 by tricine SDS-PAGE. Ac-
tive fractions were concentrated and desalted using a Centricon microcon-
centrator (Amicon, Beverly, MA) with a 10-kDa molecular mass cut-off
membrane. A Mono Q (HR 5/5) column (0.5 3 5.0 cm) from the Phar-
macia fast protein liquid chromatography (FPLC)3 system was equilibrated
with 0.05 M pyridine-acetate buffer (pH 6.0), loaded with the pooled active
fractions from the pepstatin A-Agarose step, and eluted with a gradient of
0–1.0 M ammonium acetate in a total volume of 50 ml of the starting
buffer. Two separate components with buforin I-producing activity were
isolated, and each component was further purified by a second pass over
the Mono Q column. The purified proteases were concentrated to ;1
mg/ml using the Centricon microconcentrator. Protein concentration was
determined using a bicinchoninic acid protein assay (Pierce, Rockford, IL)
with BSA as a standard.
Purification of the peptide generated from histone H2A by
specific proteases
Calf thymus histone H2A (100 mg) was incubated for 1 h at room tem-
perature with each of the purified toad stomach proteases (3 mg/reaction)
and porcine pepsin A in 100 ml of 50 mM sodium acetate (pH 3.0) con-
taining 50 mM NaCl. Samples from the protease reactions were injected
into a Waters HPLC system equipped with a C18 reversed-phase column
(3.9 3 300 mm, Delta Pak, Millipore, Milford, MA). A linear gradient of
0–100% buffer B (buffer A, 0.1% trifluoroacetic acid (TFA) in H2O; buffer
B, 0.1% TFA in acetonitrile) was established over a period of 2 h at a flow
rate of 1 ml/min. Fractions corresponding to each peak were lyophilized,
resuspended in water, and analyzed by tricine SDS-PAGE.
Antimicrobial activity assay
The antimicrobial activity of HPLC fractions of protease-digested histone
H2A was examined by the radial diffusion assay on a Bacillus subtilis lawn
as described by Lehrer et al. (17).
Structural analyses
The m.w. of the processed peptide presumably corresponding to buforin I
was determined by matrix-associated laser desorption ionization mass
spectroscopy (Kratos Kompact MALDI, Manchester, U.K.). Lyophilized
peptide (;1 nmol) was dissolved in 50% acetonitrile containing 7% (w/v)
sinapinic acid and mixed with a platinum probe. After removing the solvent
in warm air, the peptide that had been adsorbed to the platinum probe was
applied to a vacuum chamber and analyzed. Peptides were hydrolyzed by
incubation in evacuated tubes with 6 M HCl containing 0.1% phenol at
110°C for 24 h. The total composition of the peptide was determined using
a Pico-tag analysis system on a Beckman 121 MB amino acid analyzer
(Fullerton, CA). The N-terminal sequence analyses of the processed pep-
tide and purified proteases were performed by automatic Edman degrada-
tion in a gas phase sequencer (Applied Biosystems, Foster City, CA).
Ab preparation
The mouse mAbs to histone H2A (BWA3) and histone H2B (LG2-2) were
obtained from Monestier et al. (18). We purchased a rabbit polyclonal Ab
to acetylated (Ac-Lys5) histone H2A (Serotec, Oxford, U.K.) and a mouse
mAb to histone H1 (clone AE-4, Santa Cruz Biotechnology, Santa Cruz,
CA). The Ab to buforin I was elicited in rabbits by injection of a synthetic
peptide after conjugation via an added C-terminal cysteine residue to key-
hole limpet hemocyanin (Pierce). The peptide used to generate the buforin
I Ab was prepared on the basis of the following amino acid sequence:
RAGLQFPVGRVHRLLRKG (aa 20–37 of histone H2A). This sequence
includes the C-terminal 18 residues of buforin I. New Zealand White rab-
bits were immunized at 2-wk intervals with four s.c. injections of 200 mg
of the peptide conjugate mixed with Freund’s adjuvant (Sigma). The Ab
directed against toad pepsin C was produced in rabbits by injection of 20
mg of purified toad pepsin C mixed with Freund’s adjuvant. Ab specificity
was determined by ELISA using the peptide as a competitor (Pierce).
Immunohistochemistry
Fresh toad stomach tissue was placed in 4% paraformaldehyde dissolved in
PBS, incubated overnight at 4°C, and embedded in paraffin. Serial cross-
sections (4 mm) of the embedded toad stomach were deparaffinized, treated
with 0.3% hydrogen peroxide in methanol for 30 min, and washed exten-
sively, first with water and then with PBS. Immunostaining was performed
using a biotin-avidin-peroxidase method (Vectastain ABC Elite kit, Vector,
Burlingame, CA) according to the manufacturer’s protocol. Briefly, the
sections were incubated with 1% normal blocking serum for 20 min at
room temperature and then incubated for 1 h with the respective Abs:
anti-unacetylated histone H2A (20 mg/ml), anti-buforin I (1/2000 dilution),
anti-pepsin C (1/1000 dilution), anti-acetylated histone H2A (1/3000 dilu-
tion), anti-histone H1 (10 mg/ml), and anti-histone H2B (10 mg/ml). Sec-
tions were developed with chromogen diaminobenzidine for 10 min and
then counterstained with Mayer’s hematoxylin, dehydrated, and mounted.
Reagents for the hematoxylin and eosin stain and the periodic acid-Schiff
(PAS) stain were obtained from Poly Scientific (Bay Shore, NY). Control
incubations were performed using equivalent dilutions of rabbit preim-
mune serum as a primary Ab.
Immunoelectron microscopy
Fresh toad stomach tissue was fixed in 4% paraformaldehyde and 0.5%
glutaraldehyde in PBS, incubated overnight at 4°C, and washed in PBS.
Sections (50 mm) were incubated with anti-histone H2A mAb (50 mg/ml)
or anti-buforin I polyclonal Ab (1/1000 dilution). Labeled Abs were de-
tected with the Vectastain Elite ABC kit described above. After develop-
ment of peroxidase activity, sections were postfixed, dehydrated in ascend-
ing grades of alcohol, embedded in Epon resin, and allowed to polymerize
at 60°C for 2 days. Thin sections were cut and stained with 1% toluidine
blue. The regions of interest were selected, and ultrathin sections, silver
colored, were examined by transmission electron microscope.
Preparation of peptide samples from gastric luminal lavage
Anesthetized toads were surgically prepared for the collection of gastric
luminal lavage samples. The lumen of each resected stomach was perfused
with a 0.9% saline (NaCl) solution in the presence of pepstatin A (50 mM).
After cells and particulates were removed by centrifugation, the perfusate
was acidified with glacial acetic acid to a final concentration of 5%. The
lavage was then subjected to reversed-phase concentration with a Sep-Pak
C18 cartridge (Millipore) that had been activated with 80% (v/v) acetoni-
trile containing 0.1% (v/v) TFA and flushed with 0.1% (v/v) TFA to re-
move excess acetonitrile. After being loaded with the lavage fluid, the
cartridge was washed with 20 ml of 0.1% (v/v) TFA, and the peptides
trapped in the cartridge were eluted with 5 ml of 80% (v/v) acetonitrile
containing 0.1% (v/v) TFA. The eluate was then lyophilized and subse-
quently resuspended in 10 mM Tris-HCl (pH 7.5) containing 10 mM NaCl.
Western blot analysis
For immunoblot analysis of buforin I and histone H2A, the samples con-
taining an equal amount of protein (10 mg) were separated by discontin-
uous 16.5% tricine SDS-PAGE and blotted onto nitrocellulose membranes
(0.2 mm pore size; Bio-Rad, Hercules, CA) by semidry electrophoretic
transfer (Bio-Rad). Nonspecific protein binding sites were blocked with 25
mM Tris-HCl (pH 7.2), 150 mM sodium chloride, and 0.05% Tween-20
containing 3% BSA. Membranes were incubated with either a mAb to
histone H2A (2 mg/ml) or a polyclonal Ab to buforin I (1/4000 dilution) for
3 Abbreviations used in this paper: FPLC, fast protein liquid chromatography; TFA,
trifluoroacetic acid; PAS, periodic acid-Schiff.
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1 h at room temperature in 25 mM Tris-HCl (pH 7.2), 150 mM sodium
chloride, and 0.05% Tween-20 containing 0.5% BSA. The second Ab was
an anti-mouse IgG or anti-rabbit IgG conjugated with HRP (Amersham,
Aylesbury, U.K.). Immunoreactivity was visualized by enhanced chemi-
luminescence (ECL kit, Amersham).
Results
Purification of specific proteases responsible for buforin I
production
As a preliminary experiment we studied the specific proteolytic
activity in crude toad stomach extracts that converts histone H2A
to buforin I. The crude extracts showed a buforin I-producing ac-
tivity that functioned best under acidic conditions (pH range, 1.0–
5.0) and displayed optimal activity at a pH of about 3.0 (data not
shown). Enzyme inhibition studies showed that the production of
buforin I from histone H2A by the crude toad stomach extracts was
completely abolished by pepstatin A, a strong aspartic acid pro-
tease inhibitor (data not shown). However, serine protease inhib-
itors such as PMSF and leupeptin, metalloprotease inhibitor
EDTA, and cysteine protease inhibitor E-64 had no effect on the
buforin I-producing activity. The pH optimum of the reaction and
the fact that pepstatin A inhibited buforin I production suggested
the involvement of acid protease(s). Therefore, a pepstatin A-Aga-
rose column was used as a first step in the purification of the
buforin I-producing protease(s). The fraction from the pepstatin
A-Agarose column that contained proteolytic activity was sepa-
rated further into two discrete protein fractions by chromatography
on an FPLC Mono Q column (Fig. 1A). Each of the fractions
contained a single protein band of identical size (m.w. of
;30,000), as determined by SDS-PAGE (Fig. 1B). Both protein
bands displayed buforin I-producing proteolytic activity.
The two purified proteins showing the buforin I-producing ac-
tivity were subjected to automated Edman degradation for amino
acid sequence analysis, which allowed identification of the N-ter-
minal 20 aa residues (Fig. 1C). We searched the National Center
for Biotechnology Information data bank using the BLAST net-
work service and found that the amino acid sequences from the
amino terminus of the buforin I-producing enzymes closely
matched the N-terminal sequence of pepsin C, especially that of
bullfrog pepsin C (19). Therefore, we named the two purified bu-
forin I-producing proteases pepsin Ca and Cb. The N-terminal
amino acid sequences of pepsin Ca and Cb were identical with 18
of 20 and 19 of 20 amino-terminal residues of the bullfrog pepsin
C, respectively. The proteolytic activities of pepsin Ca and Cb
were tracked throughout the purification by determination of the
molecular size and antimicrobial activity of the processed buforin
I peptide (Fig. 2, A and B). The amino acid composition and se-
quence of the processed peptide were identical with those of bu-
forin I. In repeated mass analysis, the active peptide was found to
have a mean mass value of 4279.9 Da, which was in good agree-
ment with the theoretical molecular mass of buforin I. On the basis
of the above results, we concluded that the pepsin isozymes,
termed pepsin Ca and Cb, cleaved the Tyr39-Ala40 bond of histone
H2A to produce buforin I.
Proteolytic processing of histone H2A by porcine pepsin A
Pepsin A, a principal class of pepsins in vertebrate stomachs, was
tested for its ability to process histone H2A to yield buforin I.
Purified porcine pepsin A (purchased from Sigma) was further
purified to remove any contaminants by chromatography over a
Mono Q column. Digestion of calf thymus histone H2A with the
purified porcine pepsin A resulted in one distinct peptide band on
FIGURE 1. Purification of specific proteases. A, Chromatography on an
FPLC Mono Q column of active fractions obtained from the pepstatin
A-Agarose affinity purification step. The column was equilibrated with
0.05 M pyridine-acetate buffer, pH 6.0, and eluted with a gradient of 0–1.0
M ammonium acetate in the same buffer. B, SDS-PAGE analysis of puri-
fied specific proteases. FPLC fractions with buforin I-producing activity
were subjected to 12.5% SDS-PAGE. C, Alignment of amino acid se-
quences of purified specific proteases. The multiple sequence alignment
was obtained using the CLUSTAL W program with default parameters.
The amino acid sequences of specific toad proteases (designated pepsin Ca
and Cb) are aligned with those of bullfrog pepsin C, rat pepsin C, human
pepsin C, guinea pig pepsin C, porcine pepsin C, and porcine pepsin A.
Deletions of amino acids are indicated with hyphens. Asterisks and dots
indicate perfect matches of amino acids and conservative substitutions,
respectively. Residues identical in two or more sequences are boxed.
FIGURE 2. In vitro production of buforin I. A, Tricine SDS-PAGE
analysis of processed histone H2A by toad pepsins Ca and Cb. Histone
H2A and buforin I were loaded as controls. B, Reversed-phase HPLC of
the processed histone H2A on a Delta Pak C18 column. The column was
eluted using a linear gradient of acetonitrile (0–100%) containing 0.1%
TFA at a flow rate of 1 ml/min. The peak indicated by an arrow was found
by structural analyses to represent buforin I. C, Tricine SDS-PAGE anal-
ysis of processed histone H2A by porcine pepsin A. D, Reversed-phase
HPLC of the processed histone H2A on a Delta Pak C18 column.
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a tricine SDS-polyacrylamide gel (Fig. 2C) whose m.w. was sim-
ilar to that of buforin I. The proteolytic reaction mixture was also
fractionated by reversed-phase HPLC to isolate the processed pep-
tide (Fig. 2D). The major peptide peak showing strong antimicro-
bial activity was then subjected to structural analyses to charac-
terize the processed peptide. We obtained results identical with
those of experiments with the purified toad pepsin Ca and Cb.
Taken together, these findings indicate that porcine pepsin A can
also produce buforin I from histone H2A by cleaving preferentially
the Tyr39-Ala40 bond.
Buforin I production in the toad gastric tissue
Immunohistochemical experiments were performed to determine
the histological location of histone H2A and buforin I in the cross-
section of the toad stomach (Fig. 3). To distinguish the histone
H2A present in cytoplasm from that in nucleus, two specific Abs,
anti-acetylated (Ac-Lys5) histone H2A and anti-unacetylated his-
tone H2A, were used. As shown in Fig. 3D, the mAb to unacety-
lated histone H2A stained the cytoplasm of gastric gland cells with
a granular pattern, indicating that the unacetylated histone H2A
protein, the precursor of buforin I, was present in the cytoplasm of
the gland cells of toad gastric mucosa. The mAb used was specific
for the unacetylated histone H2A in the cytoplasm and did not
recognize the acetylated histone H2A in the nucleus (Fig. 3, D and
G) or buforin I (Fig. 3E). The stomach section subjected to PAS
staining indicates that cells immunopositive for histone H2A were
not the PAS-positive cells that are responsible for the generation of
mucus present in the gastric pit and the neck region of the gastric
gland (Fig. 3B). Incubation of the stomach sections with a poly-
clonal Ab to buforin I localized the immunoreactivity to the mu-
cosal surface of the stomach (Fig. 3E). The polyclonal Ab was
specific for buforin I and did not recognize nuclear or cytoplasmic
histone H2A (Fig. 3E). Control sections of the toad stomach in-
cubated with preimmune serum showed no immunoreactivity (Fig.
3C). A polyclonal Ab specific to toad pepsin C showed the same
strong, punctate staining pattern as that of the unacetylated histone
H2A (Fig. 3F), which suggests the possible secretion of histone
H2A into the lumen, similar to the secretion of pepsinogen C by
gastric gland cells. This suggests that histone H2A may be secreted
into the lumen in a similar way as pepsinogen C. To study the
presence of other histone proteins in the cytoplasm of the toad
stomach, the parallel sections of the toad stomach were stained
using mAbs to histone H1 (clone AE-4) and histone H2B (clone
LG2-2). Of special interest is the finding that histone H1 and H2B
were localized in the cytoplasm of toad gastric gland cells in ad-
dition to the nucleus (Fig. 3, H and I), but the granularities of
staining were much finer than that of histone H2A.
Our observations made by immunohistochemistry were further
confirmed using immunoelectron microscopy on the toad gastric
mucosa. Examination under an electron microscope showed his-
tone H2A over endoplasmic reticulum of some gastric gland cells
(Fig. 4A) and also located in the granule (Fig. 4B). In contrast,
buforin I was associated with epithelial surface (Fig. 4C).
Buforin I secretion in the vertebrate gastric lumen
Western blot analysis was then performed to examine the presence
of buforin I in the gastric lumen. Analysis of gastric luminal lavage
fluids identified an immunoreactive peptide corresponding to the
FIGURE 3. Immunohistochemistry of the cross-sectioned toad stomach. A, Hematoxylin-eosin staining was included to show gastric mucosal mor-
phology. B, PAS reaction stained carbohydrate with a pink color in a mucous gland. C, There was no immunoreactivity detected with preimmune serum.
D, Strong immunostaining for histone H2A, indicated by arrows, was seen in the cytoplasm of gland cells of toad gastric mucosa. The inset clearly indicates
a granular staining pattern for histone H2A in the cytoplasm of gastric gland cells. E, Intense dark staining for buforin I, indicated by arrows, was seen
on the mucous surface of the stomach. F, Pepsinogen C showed the same immunolocalization as that of histone H2A. G, Strong immunostaining for
acetylated (Ac-Lys5) histone H2A was seen in the nucleus of gastric gland cells. H and I, Histone H1 (H) and histone H2B (I) immunoreactivities were
seen in the cytoplasm as well as in nucleus of gastric gland cells. Bar 5 100 mm.
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purified buforin I, indicating that the peptide is released from hi-
stone H2A by pepsin C cleavage and resists degradation in the
gastric lumen (Fig. 5). Additional experiments were performed to
determine whether buforin I could also be found in the stomach of
other vertebrates. Gastric tissues from porcine, bovine, and human
species were subjected to lavage, and the fluid was collected for
partial purification by reversed-phase concentration. Fig. 6 shows
the presence of an immunoreactive peptide in porcine, bovine, and
human stomachs that comigrated with the purified buforin I. In
bovine and human gastric lavage fluids, one band corresponding to
buforin I was detected, whereas two forms of the peptide were
detected in porcine gastric fluid, indicating the presence of buforin
I and a further processed form of the antimicrobial peptide.
Discussion
In this study we have demonstrated that the antimicrobial peptide
buforin I is generated from the unacetylated histone H2A in the
cytoplasm of gastric gland cells by the action of pepsin C isozymes
in the toad stomach. Pepsin C isozymes, Ca and Cb, carry out the
production of buforin I from histone H2A by cleaving specifically
the Tyr39-Ala40 bond of histone H2A, as confirmed by structural
and immunological analyses of the processed peptide. The verte-
brate stomach contains two immunologically and biochemically
distinct groups of pepsin precursors, namely pepsinogens A and C.
Pepsinogen A is localized mainly in the fundus, whereas pepsino-
gen C is distributed throughout the stomach and proximal duode-
num (20–22). Those pepsinogens are secreted into the gastric lu-
men and activated autocatalytically to active pepsins under the
acidic condition (23, 24). The relative contents of pepsins A and C
in the vertebrate stomach differ depending on the species of the
animal. In frogs and rodents pepsin C is the major protease found
in gastric fluid, while in other vertebrates pepsin A is more abun-
dant (19–22). Therefore, we also examined the buforin I-produc-
ing ability of pepsin A, which is present as a major protease in the
gastric fluids of most vertebrates. Pepsin A also cleaved preferen-
tially the Tyr39-Ala40 bond of histone H2A to produce buforin I,
even though the buforin I-producing activity was less than that of
the toad pepsin C isozymes.
To elucidate the mechanism of buforin I generation in the toad
stomach, we used immunohistochemical methods and an Ab raised
against buforin I in rabbits immunized with a synthetic peptide
containing residues 20–37 of buforin I. This synthetic peptide was
suitable to elicit an Ab that was specific for buforin I. The buforin
I-specific Ab was immunologically unreactive with respect to both
nuclear and cytoplasmic histone H2As. A mapping study of the
linear histone H2A regions revealed that the peptide sequence of
the synthetic congener buforin I is not localized on the surface of
histone H2A protein, and therefore histone H2A is not accessible
to the buforin I Ab (25). A mAb (BWA3) to unacetylated histone
H2A was used for the detection of histone H2A in the cytoplasm.
The specificity of BWA3 was previously reported (18). Immuno-
histochemical and immunoelectron microscopic analyses revealed
that buforin I is present extracellularly on the mucosal surface,
whereas unacetylated histone H2A is distributed in both the cyto-
plasmic granules and the cytoplasm of gastric gland cells (Fig. 4,
A and B), and Western blot analysis confirmed the presence of
buforin I in luminal lavage from the stomach. The anti-acetylated
histone H2A, whose epitope lies on SGRGAcKQGGK (aa 1–9 of
histone H2A and buforin I; AcK indicates the acetylated lysine),
stained the nucleus only, not the cytoplasm. This further indicates
that histone H2A in the cytoplasm is the unacetylated one. If bu-
forin I is derived from the acetylated histone H2A in the nucleus,
buforin I on the mucosal surface also should be immunostained by
the anti-acetylated histone H2A, and acetylated lysine residue
should be detected in the amino acid analysis of buforin I obtained
from the lumen. However, buforin I on the mucosal surface was
not immunostained by the anti-acetylated histone H2A, and the
acetylated lysine residue was not detected by the amino acid anal-
ysis of buforin I. The distinct subcellular distribution of the unac-
etylated histone H2A and the detection of the unacetylated buforin
I both on the mucosal surface and in the lumen suggest that buforin
I is produced from the cytoplasmic unacetylated histone H2A se-
creted into the gastric lumen and subsequently processed by pep-
sins. This idea was further supported by the observation that toad
FIGURE 4. Immunoelectron microscopy of a section of toad gastric
mucosa. A, Extensive immunoreactivity to histone H2A was seen over
endoplasmic reticulum of gastric gland cells. B, Immunoreactive histone
H2A was present in the granule of gastric gland cell. C, Immunoreactive
buforin I was present on the surface epithelium. Bar 5 0.1 mm.
FIGURE 5. Western blot analysis of gastric lavage fluids from the per-
fused toad stomach. A, Tricine SDS-PAGE analysis of gastric lavage fluids.
The standards are 1 mg of histone H2A and 0.4 mg of purified buforin I.
B, Western blot analysis demonstrated the presence of immunoreactive
buforin I in the gastric luminal lavage fluid. The Western blots were probed
with preimmune serum, anti-histone H2A mAb, or anti-buforin I poly-
clonal Ab. Each lane contains 10 mg of extracts.
FIGURE 6. Western blot analysis of gastric lavage fluids from porcine,
bovine, and human stomachs. Gastric lavage fluids were collected and
concentrated using a Sep-Pak C18 cartridge as described in Materials and
Methods. The standard is 50 ng of purified buforin I. Western blot analysis
demonstrated the presence of immunoreactive buforin I in porcine, bovine,
and human gastric lavage fluids. Each lane contains 10 mg of extracts.
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pepsinogen C showed the same immunolocalization in the cyto-
plasm as that of the unacetylated histone H2A (Fig. 3F), which
indirectly indicates that the unacetylated histone H2A is secreted
into the lumen in a similar way as pepsinogen C.
It seems that a large amount of unacetylated histone H2A is
available in the cytoplasm of toad gastric gland cells in part be-
cause of the rapid regeneration of the gastric mucosa and active
transcription of gastric gland cells causing high expression of hi-
stone proteins. Of the histone H2A synthesized, a limited amount
moves into the nucleus and is acetylated (26), and the excess un-
acetylated histone H2A accumulates in the cytoplasm, eventually
secreted into the lumen. While the functional role of acetylation is
poorly understood, it is thought to play a role in the formation of
either newly synthesized or transcriptionally competent chromatin
(27–29). We also observed the immunoreactivity to unacetylated
histone H2A in the endoplasmic reticulum of some gastric gland
cells, which would be wholly consistent with de novo histone syn-
thesis in the cytoplasm.
Recently, the presence of histones in both the cytoplasm and the
nucleus has been reported (3, 30–34), and secretion of histone
proteins into extracellular milieu was also observed (35–38). Now
it is clear that histone proteins are present in both the cytoplasm
and the nucleus of rapidly regenerating or transcriptionally active
cells such as stomach epithelial cells.
Until recently, the functional role of histones has been viewed
mainly in connection with DNA stabilization and gene expression.
However, there is growing evidence that histones may be involved
in a multitude of biological functions (39–43), including host de-
fense (33, 39). The generation of antimicrobial peptide buforin I
may be one of its secondary biological functions.
It seems that the expression of buforin I is not up-regulated
during infections, and cytokines do not play a role in the produc-
tion of buforin I. Instead, buforin I production is closely related to
the secretion of hydrochloric acid and pepsinogen. The toad, in
common with other anurans, swallows its prey intact, and stores its
food for some period of time before digestion begins, so the se-
cretion of antimicrobial peptides into the stomach lumen may
serve to inhibit bacterial growth. Once the food is ingested into the
stomach, it signals cells in the stomach wall to secrete the hydro-
chloric acid and pepsinogen, thus contributing to the production of
buforin I from histone H2A.
Of note is the finding that the immunoreactivity of buforin I is
extracellular on the mucosal surface. This indicates that buforin I
coats the mucosal surface, where it may contribute to the estab-
lishment of a local antimicrobial milieu. It is suggested that anti-
microbial peptides present on the mucosal surfaces of vertebrates
may serve as a defense of the gastrointestinal tract against micro-
bial invasion or to aid in wound repair (44). For pathogens that
invade the host, surface epithelium is the first site of contact with
the host. Microbial pathogens that breach the epithelial barrier can
cause an acute inflammatory response that is characterized by in-
creased expression of cytokines with chemoattractant and proin-
flammatory functions. Thus, the presence of buforin I on the mu-
cosal surfaces may contribute to maintain mucosal barrier function
in conjunction with mucosal immune cells. Further studies are nec-
essary to examine the relationship between buforin I and mucosal
immune cells.
It is well established that most amphibian functional peptides
have either identical or closely related counterparts in the mam-
malian brain and gastrointestinal tract (45). Whether buforin I is
ubiquitous in the stomachs of vertebrates is not yet clear. However,
we confirmed its presence in the lavage fluids of porcine, bovine,
and human stomachs by Western immunoblot analysis (Fig. 6).
Our results in this study suggest that antimicrobial peptides, such
as buforin, act in conjunction with gastric hydrochloric acid to
enable the stomach to contribute to the innate defense of more
distal intestinal organs.
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